Restless legs syndrome in Parkinson’s disease

Akhmadulina A.O.; Levin O.S.; Poluektov M.G.

doi:https://doi.org/10.17116/jnevro202012010280

Close metadata

Recommended articles:

Sleep disorders in patients with Lewy body dementia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87

Art and creativity in Parkinson’s disease: the mysterious effects of dopamine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20

Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67

Diagnosis of pathological and adaptive balance changes in Parkinson’s disease to select a rehabilitation program. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):88-94

Potential and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medicine. 2025;(7):94-99

Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14

Dynamics of permeability of the blood-brain barrier after FUS thalamotomy according to contrast-enhanced MRI. Burdenko's Journal of Neurosurgery. 2025;(4):51-60

Change of speech disorders during bilateral deep stimulation of the subthalamic nucleus of the brain in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):59-65

Sleep disorders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132

Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

Abstract:

Disturbances in sleep and wakefulness are important symptoms of Parkinson’s disease (PD) and are associated with negative effects on patients’ quality of life. The analysis of literature on the relationship between RLS and PD revealed three main hypotheses explaining the relatively high incidence of RLS in PD: (1) RLS can be considered as an early (prodromal) manifestation or a predictor of PD that can outpace its main symptoms by several years (by analogy with conduct disorder during sleep with REM); (2) the high incidence of RLS in the advanced stage of PD may be associated with augmentation of previously latent RLS symptoms during prolonged dopaminergic therapy of PD; (3) a significant proportion of RLS cases in PD patients are not «classical» RLS, but represent, for example, manifestations of motor or non-motor fluctuations or a special form of stereotypy in the legs. Further research is needed to determine if any of these statements are true.

Keywords:

restless legs syndrome

Parkinson’s disease

leg stereotypes

periodic limb movements

Parkinson’s disease

periodic limb movements

restless legs syndrome

leg stereotypes

Parkinson’s disease

periodic limb movements

restless legs syndrome

leg stereotypes

Parkinson’s disease

periodic limb movements

leg stereotypes

Parkinson’s disease

periodic limb movements

Authors:

Akhmadulina A.O.

Russian Medical Academy of Continuous Professional Education

Akhmadulina A.O.

Russian Medical Academy of Continuous Professional Education

Levin O.S.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 5342-1373
Scopus AuthorID: 57147160800
ORCID: 0000-0003-3872-5923

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

ResearcherID: J-7369-2016
ORCID: 0000-0001-6215-0918

Akhmadulina A.O.

Russian Medical Academy of Continuous Professional Education

Received:

11.08.2020

Accepted:

25.08.2020

Close metadata

References:

Somnologiya i meditsina sna. Nats. ruk. pamyati A.M. Veina i Ya.I. Levina. Pod. red. Poluektova M.G. M.: Medforum; 2016. (In Russ.).
Allen R, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119. https://www.ncbi.nlm.nih.gov/pubmed/14592341
Levin OS. Podkhody k diagnostike i lecheniyu sindroma bespokoinykh nog. Trudnyi Patsient. Aprel’ 2009. Accessed March 30, 2019 (In Russ.). https://t-pacient.ru/articles/6439/
Garcia-Borreguero Diego D, Stillman P, Benes H, Buschmann H, Chaudhuri KR, Rodríguez VM Gonzalez, Högl B, Kohnen R, Monti G Carlo, Stiasny-Kolster K, Trenkwalder C, Williams AM. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurology. 2011;11:28. https://doi.org/10.1186/1471-2377-11-28
Ketaki Bhalsing K Suresh, Uday B Muthane, Pramod Kr Pal. Prevalence and profile of Restless Legs Syndrome in Parkinson’s disease and other neurodegenerative disorders: A case-control study. Parkinsonism & Related Disoders. 2013;19:426-430. https://doi.org/10.1016/j.parkreldis.2012.12.005
Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria — history, rationale, description, and significance. Sleep Medicine. 2014;15(8):860-873. https://doi.org/10.1016/j.sleep.2014.03.025
Levin O.S. Sindrom bespokoinykh nog (bolezn’ Villiziya-Ekboma). (In Russ.).
Renato Puppi Munhoz, Maria CL Constantino, Laura Silveira-Moriyama. The Parkinson’s disease and restless legs syndrome/Willis-Ekbm disorder link: evidences, biases and clinical relevance. Arquivos de Neuro-Psiquiatria. 2019;77(1):47-54. https://doi.org/10.1590/0004-282x20180125
Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. 2012;16:987-1007. https://doi.org/10.1007/s11325-011-0606-x
Nomura T, Inoue Y, Kusumi M, Uemura Y, Nakashima K. Prevalence of restless legs syndrome in a rural community in Japan. Movement Disorders. 2008;23(16):2363-2369. https://doi.org/10.1002/mds.22274
Mizuno S, Miyaoka T, Inagaki T, Horiguchi J. Prevalence of restless legs syndrome in non-institutionalized Japanese elderly. Psychiatry and Clinical Neurosciences. 2005;59(4):461-465. https://doi.org/10.1111/j.1440-1819.2005.01399.x
Kim T-J. Restless Legs Syndrome in Korean Adults: A Study in Two Independent Samples of the General Population. Neuroepidemiology. 2019;52:193-204. https://doi.org/10.1159/000496839
Peralta CM, Frauscher B, Seppi K, et al. Restless legs syndrome in Parkinson’s disease. Movement Disorders. 2009;24:2076-2080. https://doi.org/10.1002/mds.22694
Hogl B, Stefani A. Restless legs syndrome and periodic leg movements in patients with movement disorders: specific considerations. Movement Disorders. 2017;32:669-681. https://doi.org/10.1002/mds.26929
Angelini M, Negrotti A, Marchesi E, Bonavina G, Calzetti S. A study of the prevalence of restless legs syndrome in previously untreated Parkinson’s disease patients: absence of co-morbid association. Journal of the Neurological Sciences. 2011;310:286-288. https://doi.org/10.1016/j.jns.2011.08.012
Calzetti S, Negrotti A, Bonavina G, Angelini M, Marchesi E. Restless legs syndrome and Parkinson’s disease. Movement Disorders. 2010;25:1314-1315. https://doi.org/10.1002/mds.23097
Gjerstad MD, Tysnes OB, Larsen JP. Increased risk of leg motor restlessness but not RLS in early Parkinson disease. Neurology. 2011;77(22):1941-1946. https://doi.org/10.1212/WNL.0b013e31823a0cc8
Loo HV, Tan EK. Case — control study of restless legs syndrome and quality of sleep in Parkinson’s disease. Journal of the Neurological Sciences. 2008;266:145-149. https://doi.org/10.1016/j.jns.2007.09.033
Suzuki K, Miyamoto M, Miyamoto T, Tatsumoto M, Watanabe Y, Suzuki S. Nocturnal disturbances and restlessness in Parkinson’s disease: using the Japanese version of the Parkinson’s disease sleep scale-2. J Journal of the Neurological Sciences. 2012;318:76-81. https://doi.org/10.1016/j.jns.2012.03.022
Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson’s disease. Journal of the Neurological Sciences. 2002;196:33-36. https://doi.org/10.1016/s0022-510x(02)00020-5
Verbaan D, Rooden SM, Hilten JJ, Rijsman RM. Prevalence and clinical profile of restless legs syndrome in Parkinson’s disease. Movement Disorders. 2010;25(13):2142-2147. https://doi.org/10.1002/mds.23241
Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y. Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson’s disease: A multicenter case-controlled study. Parkinsonism and Related Disorders. 2017;44:18-22. https://doi.org/10.1016/j.parkreldis.2017.08.007
Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67(1):125-130.
Rye DB. Parkinson’s disease and RLS: the dopaminergic bridge. Sleep Med. 2004;5:17-28. https://doi.org/10.1016/j.sleep.2004.01.016
Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology. 1999;52(5):932-937. https://doi.org/10.1212/wnl.52.5.932
Earley CJ, Kuwabara H, Wong DF, Gamaldo C, Salas RE, Brašic JR. Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep. 2013;36(1):51-57. https://doi.org/10.5665/sleep.2300
Allen RP, Connor JR, Hyland K, Earley CJ. Abnormally increased CSF 3-ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis. Sleep Med. 2009;10:123-128. https://doi.org/10.1016/j.sleep.2007.11.012
Khan FH, Ahlberg CD, Chow CA, Shah DR, Koo BB. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome. Journal Neurology. 2017;264:34-41. https://doi.org/10.1007/s00415-017-8431-1
Ryu JH, Lee MS, Baik JS. Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson’s disease. Parkinsonism and Related Disorders. 2011;17(3):201-203. https://doi.org/10.1016/j.parkreldis.2010.11.014
Bianco LE, Unger EL, Earley CJ. Iron deficiency alters the day-night variation in monoamine levels in mice. Chronobiol Int. 2009;26:447-463. https://doi.org/10.1080/07420520902820905
Garcia-Borreguero D, Williams AM. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev. 2010;14:339-346. https://doi.org/10.1016/j.smrv.2009.11.006
Garcia-Borreguero D. Augmentation of restless leg syndrome (WillisEkbom disease) during long-term dopaminergic treatment. Postgrad Med. 2015;127(7):716-725. https://doi.org/10.1080/00325481.2015.1058140
Garcia‐Borreguero D, Allen RP, Kohnen R. On behalf of the International Restless Legs Syndrome Study Group. Diagnostic standards for dopaminergic augmentation of Restless Legs Syndrome: report from a World Association of Sleep Medicine‐International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007;8:520-530. https://doi.org/10.1016/j.sleep.2007.03.022
Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol. 2006;5:878-886. https://doi.org/10.1016/S1474-4422(06)70576-2
Jenner P, McCreary AC, Scheller DK. Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression. J Neural Transm. 2011;118:1691-702. https://doi.org/10.1007/s00702-011-0703-9
Marchesi E. A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson’s disease during chronic dopaminergic therapy. J Neurol. 2016;263(3):441-447. https://doi.org/10.1007/s00415-015-7937-7
Lee JE, Shin HW, Kim KS, Sohn YH. Factors contributing to the development of restless legs syndrome in patients with Parkinson disease. Movement Disorders. 2009;24(5):79-82. https://doi.org/10.1002/mds.22410
Ying-Shan Piao, Teng-Hong Lian, Yang Hu, Li-Jun Zuo. Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters. Scientific Reports. 2017;7:10547. https://doi.org/10.1038/s41598-017-10593-7
Gomez-Esteban JC, Zarranz JJ, Tijero B, Velasco F, Barcena J, Rouco I. Restless legs syndrome in Parkinson’s disease. Movement Disorders. 2007;22:1912-1916. https://doi.org/10.1002/mds.21624
Jankovic J. Leg stereotypy disorder. J Neurol Neurosurg Psychiatry. 2016;87:220-221. https://doi.org/10.1136/jnnp-2015-310816
Mitesh Lotia, Michele K York, Adriana M Strutt, Joseph Jankovic. Leg stereotypy syndrome: phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018;0:1-4. https://doi.org/10.1136/jnnp-2017-317057
Houdayer E, Walthall J, Belluscio Ba. Absent movement-related cortical potentials in children with primary motor stereotypies. Mov Disord. 2014;29:1134-1140. https://doi.org/10.1002/mds.25753
Ekstrapiramidnye rasstroistva. Rukovodstvo po diagnostike i lecheniyu. Pod. ped. Shtoka V.N., Ivanovoi-Smolenskoi I.A., Levina O.S. M.: MEDpress-inform; 2002. (In Russ.).
Kwatra V, Khan MA, Quadri SA, Cook TS. Differential Diagnosis and Treatment of Restless Legs Syndrome: A Literature Review. Cureus. 2018;10(9):3297. https://doi.org/10.7759/cureus.3297
Rana AQ, Khan F, Mosabbir A, Ondo W. Differentiating nocturnal leg cramps and restless legs syndrome. Expert Rev Neurother. 2014;14:813-818. https://doi.org/10.1586/14737175.2014.927734
Ferini-Strambi L. RLS-like symptoms: differential diagnosis by history and clinical assessment. Sleep Medicine. 2007;8(2):3-6. https://doi.org/10.1016/j.sleep.2007.04.009
Hamilton-Stubbs P, Walters A. Restless legs syndrome. Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment. Wiley-Blackwell Publishing. 2012;20:311-330. https://doi.org/10.1002/9781444346183.ch20
Merlino G, Serafini A, Robiony F, Valente M, Gigli GL. Restless legs syndrome: differential diagnosis and management with rotigotine. Neuropsychiatr Dis Treat. 2009;5:67-80. https://doi.org/10.2147/NDT.S3675
Tompra N, Foster C, Sanchis-Gomar F, de Koning JJ, Lucia A, Emanuele E. Upper versus lower limb exercise training in patients with intermittent claudication: a systematic review. Atherosclerosis. 2015;239:599-606. https://doi.org/10.1016/j.atherosclerosis.2015.02.038
Chokroverty S. Differential diagnoses of restless legs syndrome/Willis-Ekbom disease mimics and comorbidities. Sleep Med Clin. 2015;10:249-262. https://doi.org/10.1016/j.jsmc.2015.05.021
Becker PM, Novak M. Diagnosis comorbidities, and management of restless legs syndrome. Curr Med Res Opin. 2014;30:1441-1460. https://doi.org/10.1185/03007995.2014.918029
Lohr JB, Eidt CA, Abdulrazzaq Alfaraj A, Soliman MA. The clinical challenges of akathisia. CNS. Spectr. 2015;20(1):1-14. https://doi.org/10.1017/S1092852915000838
Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurology. 2005;4(8):465-475. https://doi.org/10.1016/s1474-4422(05)70139-3
Cotter PE, O’Keeffe ST. Restless leg syndrome: is it a real problem? Ther Clin Risk Manag. 2006;2:465-475. https://doi.org/10.2147/tcrm.2006.2.4.465
Arthur S. Walters, Birgit Frauscher. Review of Severity Rating Scales for Restless Legs Syndrome: Critique and Recommendations. Movement Disorders Clinical Practice. 2014;1(4). https://doi.org/10.1002/mdc3.12088
Garcia‐Borreguero D, Kohnen R, Hogl B. Validation of the Augmentation Severity Rating Scale (ASRS): a muticentric, prospective study with levodopa on Restless Legs Syndrome. Sleep Med. 2007;8:455-463. https://doi.org/10.1016/j.sleep.2007.03.023
Arthur S. Walters, Birgit Frauscher, Richard Allen, Heike Benes. Review of Diagnostic Instruments for the Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED): Critique and Recommendations. JCMS. 2014;10(12):1343-1349. https://doi.org/10.5664/jcsm.4298
Michaud M, Poirier G, Lavigne G, Montplaisir J. Restless legs syndrome: scoring criteria for leg movements recorded during the suggested immobilization test. Sleep Med. 2001;2:317-321. https://doi.org/10.1016/S1389-9457(00)00072-1
De Cock VC, Bayard S, Yu H, Grini M, Carlander B, Postuma R, Dauvilliers Y. Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson’s disease. Movement Disorders. 2012;27(6):743-749. https://doi.org/10.1002/mds.24969
Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep. 2000;23:361-367. https://doi.org/10.1093/sleep/23.3.1c
Yang MS, Montplaisir J, Desautels A. Valid measures of periodic leg movements (PLMs) during a suggested immobilization test using the PAM-RL leg activity monitors require adjusting detection parameters for noise and signal in each recording. Sleep Med. 2014;15:132-137. https://doi.org/10.1016/j.sleep.2013.08.788
Gschliesser V, Frauscher B, Brandauer E. PLM detection by actigraphy compared to polysomnography: a validation and comparison of two actigraphs. Sleep Med. 2009;10:306-311. https://doi.org/10.1016/j.sleep.2008.03.015
Ferri R, Fulda S, Manconi M. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index. Sleep Med. 2013;14:293-296. https://doi.org/10.1016/j.sleep.2012.08.014
Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Hogl B, et al. The long-term treatment of restless legs syndrome/Willis Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance:are port from the International Restless Legs Syndrome Study Group. Sleep Medicine. 2013;14:675-684. https://doi.org/10.1016/j.sleep.2013.05.016
Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG. Willis-Ekbom disease foundation revised consensus statement on the management of restless legs syndrome. Mayo Clinic Proceedings. 2013;88:977-986. https://doi.org/10.1016/j.mayocp.2013.06.016
Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW. Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med. 2014;370(7):621-631. https://doi.org/10.1056/NEJMoa1303646
Trenkwalder C, Benes H, Grote L, Garcia-Borreguero D, Hogl B, Hopp M. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013;12:1141-1150. https://doi.org/10.1016/S1474-4422(13)70239-4
Collado-Seidel V, Kazenwadel J, Wetter TC, Kohnen R, Winkelmann J, Selzer R. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology. 1999;52:285-290. https://doi.org/10.1212/WNL.52.2.285
Polo O, Ylä-Sahra R, Hirvonen K, Karvinen J, Vahteristo M, Ellmén J. Entacapone prolongs the reduction of PLM by levodopa/carbidopa in restless legs syndrome. Clinical Neuropharmacology. 2007;30(6):335-344. https://doi.org/10.1097/WNF.0B013E31805930C2
Shiyi Guo, Jinsha Huang. Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management Front. Frontiers in Aging Neuroscience. 2017;9:1-14. https://doi.org/10.3389/fnagi.2017.00171
Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Movement Disorders. 2008;23(16):2267-2302. https://doi.org/10.1002/mds.22254
Mackie S, Winkelman JW. Long-term treatment of restless legs syndrome (RLS): an approach to management of worsening symptoms, loss of eﬃcacy, and augmentation. CNS Drugs. 2015;29:351-357. https://doi.org/10.1007/s40263-0150250-2
Liu GJ, Wu L, Wang SL, Ding L, Xu LL, Wang YF. Incidence of augmentation in primary restless legs syndrome patients may not be that high:evidence from a systematic review and meta-analysis. Medicine. 2016;95(2):e2504. https://doi.org/10.1097/md.0000000000002504
Trenkwalder C, Benes H, Grote L, Happe S, Hogl B, Mathis J. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. Movement Disorders. 2015;22:696-703. https://doi.org/10.1002/mds.21401
Vetrugno R, La Morgia C, D’angelo R, Loi D, Provini F, Plazzi G. Augmentation of restless legs syndrome with long-term tramadol treatment. Movement Disorders. 2007;22:424-427. https://doi.org/10.1002/mds.21342
Hogl B, Garcia-Borreguero D, Kohnen R, Ferini-Strambi L, Hadjigeorgiou G, Hornyak M. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010;257:230-237. https://doi.org/10.1007/s00415009-5299-8
Oertel W, Trenkwalder C, Benes H, Ferini-Strambi L, Hogl B, Poewe W. Long-term safety and eﬃcacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. Lancet Neurology. 2011;10:710-720. https://doi.org/10.1016/S1474-4422(11)70127-2
Garcia-Borreguero D, Williams AM. An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment. Curr Opin Neurol. 2014;27:493-501. https://doi.org/10.1097/WCO.0000000000000117
Allen RP, Chen C, Garcia-Borreguero D, Polo O, Du Brava S, Miceli J. Comparison of pregabalin with pramipexole for restless legs syndrome. N Eng J Med. 2014;370:621-631. https://doi.org/10.1056/NEJMoa1303646
Rukovodstvo po diagnostike i lecheniyu bolezni Parkinsona. Pod red. Illarioshkina S.N., Levina O.S. M. 2017;336, 204-205 (In Russ.).